US FDA Commissioner’s Office Plans Involvement In Many Approvals In Potential Major Change

Stakeholders are concerned the continued involvement of Commissioner Martin Makary's special assistant in other approval procedures could jeopardize the FDA's independent review process. (Screenshot of FDA Video)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Geography